Patients with Parkinson’s disease (PD) often have difficulties with visual acuity in low-contrast images. Because they may have normal high-contrast vision, this is often overlooked during routine eye exams. In the current issue of the Journal of Parki…
Uncategorized
New bi-toric trifocal lens performs well in study
ISTANBUL — Results of a multicenter, prospective study showed that the new bi-toric trifocal AT LISA 939MP from Carl Zeiss Meditec effectively corrects presbyopia and astigmatism after cataract and refractive lens exchange.Three centers connected with the International Vision Correction Research Centre of Heidelberg University, Germany, participated in the study.
Uncategorized
NAD says B+L solution package makes no ‘comparative performance claims’
Following a challenge from Alcon, the National Advertising Division determined that “compare to” statements made by Bausch + Lomb and Wal-Mart on packaging for Equate contact lens products are not comparative performance claims requiring substantiation, according to the Advertising Self-Regulatory Council.Alcon Laboratories Inc. took issue with packaging for Equate MPS and Equate Moisture Last containing statements to compare the products to Opti-Free Replenish and Opti-Free Pure Moist, which are Alcon products, the Advertising Self-Regulatory Council (ASRC) said in a press release.
Uncategorized
VIDEO: Speaker discusses combining PRK and collagen cross-linking for keratoconus management
ISTANBUL – At the ESCRS Winter Meeting, A. John Kanellopoulos, MD, talks about combination of PRK with corneal crosslinking in the management of keratoconus. Over more than fifteen year of personal experience Kanellopoulos was able to demonstrate that topography-guided normalization of the cornea offers keratoconus patients not only stabilization but also essential refractive improvement and better visual rehabilitation.
New Diagnostic Test Proposed for Myasthenia Gravis
Ocular vestibular-evoked myogenic potentials could be used to diagnose myasthenia gravis, researchers report. Medscape Medical News
Uncategorized
Intracameral prophylaxis against endophthalmitis gaining worldwide acceptance
ISTANBUL — Intracameral administration of cefuroxime as a prophylaxis for endophthalmitis after cataract surgery has become a widespread practice in Europe and is gaining popularity in other areas of the world, according to data presented at the winter meeting of the European Society of Cataract and Refractive Surgeons.The first intracameral approach was introduced in 1977 in India by Gholam Peyman, MD. Almost 20 years later Per Montan, MD, started using intracameral cefuroxime in Sweden, and the good results inspired Peter Barry, MD, to launch the ESCRS endophthalmitis study.